Evidence map›Paper›PMID 37962905›Full record

Observational studyAnnals of the American Thoracic Society2024

Effect of COVID-19 on Bronchiectasis Exacerbation Rates: A Retrospective U.S. Insurance Claims Study.

Annika Åstrand, Steven J Kiddle, Rohith Siva Ganesh Mudedla, Sanchita Porwal, Kaushik Chafekar, Shubh Agrawal, Carlos Seminario, James D Chalmers, Ioannis Psallidas

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Annals of the American Thoracic Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Article
  4. Viruses in bronchiectasis.ERJ open research · 2025
    Review
  5. Review
  6. Article
  7. ERJ open research · 2025
    Article
  8. European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  9. Exacerbations of bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  10. Infection and the microbiome in bronchiectasis.European respiratory review : an official journal of the European Respiratory Society · 2024
    Review
  11. Bronchiectasis and COVID-19: For Better or for Worse?Annals of the American Thoracic Society · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 5 countries.

Annika ÅstrandLate-Stage Development, Respiratory & Immunology, AstraZeneca, Gothenburg, Sweden.ORCID 0000-0002-4231-6682
Steven J KiddleData Science & Advanced Analytics, Data Science & Artificial Intelligence, Research & Development, and.
Rohith Siva Ganesh MudedlaZS Associates India Pvt. Ltd., Pune, India.
Sanchita PorwalZS Associates India Pvt. Ltd., Pune, India.
Kaushik ChafekarZS Associates India Pvt. Ltd., Pune, India.
Shubh AgrawalIntegrated Evidence, ZS Associates, Bangalore, India.
Carlos SeminarioLate-Stage Development, Respiratory & Immunology, AstraZeneca, Gaithersburg, Maryland; and.
James D ChalmersDivision of Molecular and Clinical Medicine, University of Dundee, Dundee, United Kingdom.
Ioannis PsallidasLate-Stage Development, Respiratory & Immunology, AstraZeneca, Cambridge, United Kingdom.
AstraZeneca (Netherlands) · NLAstraZeneca (United Kingdom) · GBAstraZeneca (United States) · USEngineering Associates (United States) · USUniversity of Cambridge · GBUniversity of Dundee · GB

Funding

AstraZeneca
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

BronchiectasisCOVID-19InsuranceDisease ProgressionHumansPandemicsRetrospective Studiesbronchiectasisexacerbationpandemicssevere acute respiratory syndrome coronavirus 2

Identifiers

PMID37962905
PMCPMC10848910
OpenAlexW4388653522

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.